Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Protagenic Therapeutics (NASDAQ:PTIX) through any online brokerage.
Other companies in Protagenic Therapeutics’s space includes: Dermata Therapeutics Inc (NASDAQ:DRMA), Bio Green Med Solution Inc (NASDAQ:BGMSP), Can Fite Biofarma Ltd (AMEX:CANF), AquaBounty Technologies Inc (NASDAQ:AQB) and Indaptus Therapeutics Inc (NASDAQ:INDP).
There is no analysis for Protagenic Therapeutics to provide a consensus price target.
The stock price for Protagenic Therapeutics (NASDAQ: PTIX) is $1.65 last updated December 15, 2025 at 6:26 AM EST.
There are no upcoming dividends for Protagenic Therapeutics.
Protagenic Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Protagenic Therapeutics.
Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.